Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: Depression is common after stroke and is associated with increased mortality. However, there are few data on the prevalence after TIA, and it is unclear whether TIA can trigger depression and, if so, what factors might suggest susceptibility in an individual. METHODS: We completed a systematic review (Medline/PsychInfo/EMBASE searched to 20 March 2025) of published cross-sectional or cohort studies that reported the prevalence of depression at any time point after a TIA and validated the findings in an population-based cohort (Oxford Vascular Study; OXVASC). Pooled prevalence rates were calculated, risk factors reported and regression analyses were used to determine the proportion of between-study heterogeneity that could be accounted for by study methodology. RESULTS: The search identified 26 studies; 23 reported data at a uniform time point after the TIA but the prevalence rates of depression were highly heterogeneous at each time point studied (phet<0.001 at <1, 1-6 and 12 months). However, among studies with serial assessments (196 patients from 4 published longitudinal studies and 478 from OXVASC) there was less heterogeneity and the pooled prevalence of depression fell from 20.1% (16.9-23.4%;phet=0.35) at 0-1 month to 14.1% (11.5-16.7%;phet=0.40) at 3-12 months (pdiff=0.004). In the few studies that reported risk factors for depression after a TIA, younger age was the only consistent predictor, but this was similarly validated in the OXVASC population. On regression analysis for heterogeneity, 83% of the variance in prevalence rates between studies was explained by assessment method (postal questionnaire: 5.6%, 95%CI 3.1-8.1 versus face-to-face interview 17.7%, 13.7-21.7; p<0.001), the screening tool used, TIA definition and exclusion criteria. A model, based on these study methods in published studies, predicted a prevalence rate of 22.1% in OXVASC, which was close to the observed rate of 20.7% at 1-month validating the findings. CONCLUSIONS: Depression affects about 1-in-5 patients early after a TIA but prevalence falls with time, suggesting that it may be triggered by the event in some cases, but further work is required to identify risk factors. Additionally, when planning future research, investigators must remain cognisant of the significant influence that study design has on the observed prevalence rates.

More information Original publication

DOI

10.1177/17474930261432616

Type

Journal article

Publication Date

2026-03-03T00:00:00+00:00

Keywords

Risk factors, TIA, depression, mood, prognosis, validation